Opportunity Assessment
Validate Indian hospital and patient demand for your healthtech. Covers hospital CIO and clinical department interviews, regulatory mapping, competitive analysis, and a Go/Defer/Kill recommendation.
Learn more →
Our POV · 2026
India healthtech market entry strategy
India's healthtech market is one of the most significant and complex in the world – combining 1.4 billion patients across diverse healthcare infrastructure, an active digital health regulatory environment through the Ayushman Bharat Digital Mission, a rapidly growing private hospital sector, and significant government healthcare investment. International healthtech companies across telemedicine, diagnostic AI, hospital information systems, medical devices, and digital therapeutics are all evaluating India market entry. GreyRadius helps international healthtech companies navigate India's healthcare complexity with primary research, regulatory mapping, hospital system GTM, and fundraising support.
Why now? India's Ayushman Bharat Digital Mission is creating national digital health infrastructure – Health ID, ABHA, and the Health Claims Exchange are all creating interoperability infrastructure that healthtech companies can connect to. Government hospital digitalisation investment and private hospital technology upgrades are both creating significant procurement opportunities in 2024–2028.
$50B+
India digital health market by 2027
Growing at 25% annually as government digital health investment, telemedicine adoption, and hospital digitalisation all accelerate.
30+
Primary interviews per India healthtech mandate
Hospital CIOs, clinical department heads, and CDSCO regulatory specialists – every engagement grounded in direct primary research.
8 weeks
India healthtech market entry strategy delivery
AI-augmented ABDM ecosystem mapping and hospital demand research delivers India healthtech market entry strategies efficiently.
Market Intelligence
What the data says.
India's digital health market is projected to reach $50B by 2027 – growing at 25% annually as government digital health investment, telemedicine adoption, and hospital digitalisation all accelerate simultaneously.
India has a severe healthcare workforce shortage – less than 1 doctor per 1000 population versus WHO recommendation of 2.5, creating significant demand for AI diagnostics, telemedicine, and digital health tools that extend clinical capacity.
India's private hospital sector is growing at 12% annually – corporate hospital chains including Apollo, Fortis, Narayana, and Max are all investing in technology upgrades creating enterprise healthtech procurement opportunities.
Ayushman Bharat Digital Mission is creating health data interoperability – the ABDM Health ID and ABHA framework are enabling data flow between health facilities that digital health platforms can integrate with.
Market Reality
What makes this market hard.
- CDSCO medical device registration is complex – Software as Medical Device classification and approval under CDSCO medical device rules requires clinical evidence and regulatory dossiers that take 12–18 months.
- India's healthcare market is extremely price-sensitive – hospital technology budgets in India are 20–40% of equivalent budgets in developed markets, requiring market-specific pricing.
- Public and private hospital procurement processes differ dramatically – government hospital procurement through state health agencies requires tender participation while private hospitals have direct procurement processes.
- Regional language and clinical practice variation across Indian states requires significant localisation – clinical workflows in Tamil Nadu differ from those in Punjab or Maharashtra.
Our Work
What we solve for clients.
If you recognise your situation below, we can help.
India healthtech demand validation
You need to validate Indian hospital and patient demand for your healthtech product including price sensitivity and integration requirements with India health systems.
CDSCO regulatory classification and approval
You need to understand how your healthtech product is classified under Indian medical device rules and what approval timeline and evidence requirements apply.
India hospital GTM strategy
You need a go-to-market plan for Indian private and public hospital systems covering corporate chain acquisition, government tender strategy, and first-hospital deployment.
India healthtech partner identification
You need to identify hospital group technology buyers, ABDM integration partners, and clinical validation hospitals.
Raising capital for India healthtech
You need a pitch book grounded in Indian health market demand data and a credible India growth story.
Public sector health programme access
You need to identify government health programme procurement opportunities tied to Ayushman Bharat and state digital health initiatives.
Our Services
How we engage.
Every engagement is grounded in primary research and delivers a measurable outcome.
Feasibility & TEV
Full financial and operational feasibility for India healthtech investment. Covers Indian hospital adoption modelling, CDSCO compliance cost, price-adapted unit economics, and investor-ready projections.
Learn more →Market Entry Execution
End-to-end India healthtech market entry. CDSCO regulatory pathway, hospital chain GTM, ABDM integration strategy, and first-Indian-hospital deployment.
Learn more →GTM Execution-as-a-Service
Embedded India healthtech GTM team. Hospital outreach, clinical champion development, and first-revenue milestone tracking across hospital chains.
Learn more →Pitchbook & Fundraising
Investor-ready pitch books for India healthtech investment. India-health-market-validated demand data, regulatory pathway, and investor identification.
Learn more →AI Consulting
AI use-case identification for India – from Hindi and regional language clinical documentation to AI triage for India's primary care shortage and ABDM-integrated patient records.
Learn more →Why GreyRadius.
Primary research-led
80% of our insight comes from first-party interviews with buyers, competitors, and regulators – not secondary data that everyone else has.
Expert-led, AI-enabled delivery
Our AI layer compresses research timelines by 60% and surfaces pattern-matching from 200+ prior mandates – so you get faster, deeper answers.
Outcomes, not reports
We measure success by first contracts signed, capital raised, and markets entered – not deliverables produced. Every mandate has a milestone.
200+
Projects delivered
100+
SaaS & tech clients
80%
Primary research-led
4
Countries / offices
Case Studies
Mandates we've run.
HealthTech · Market Entry
HealthTech platform market entry into the GCC
Ministry interviewsRegulatory reviewPartner ecosystem
View all case studies →
HealthTech · GTM
GTM for a remote-patient-monitoring SaaS in South Asia
Clinic pipelineFirst contractsMRR target
View all case studies →
HealthTech · Assessment
Opportunity assessment for a chronic-disease app in Southeast Asia
Patient interviewsMarket sizedRevenue model
View all case studies →
FAQ
Common questions.
Does GreyRadius work with consumer digital health companies or also with hospital enterprise healthtech?+
Both. We work with consumer apps on India market entry and GTM, and with enterprise hospital technology on market entry and procurement strategy.
What India healthtech segments does GreyRadius focus on?+
Diagnostic AI, telemedicine, hospital information systems, medical devices, and digital therapeutics – segments with active India procurement.
How long does an India healthtech market entry engagement take?+
Typically 8–12 weeks for hospital demand research, CDSCO regulatory mapping, and GTM strategy.
Can GreyRadius identify government health programme opportunities for healthtech companies?+
Yes. Ayushman Bharat programme mapping and state health authority identification are part of our India healthtech market entry service.
Stay informed
Market intelligence for HealthTech leaders.
GreyRadius research notes, market entry signals, and sector briefs – delivered weekly. No fluff.
Not sure which engagement fits? Take our free 2-minute diagnostic →
Ready to enter this market?
Primary research. AI-enabled analysis, expert-reviewed. Outcomes-based delivery – across Gulf, Southeast Asia, South Asia.
Book a call